Showing results (61-70 of 173) with videos related to
Sort By:
Pageof 18
Blood|July 17, 2015
How I treat catastrophic thrombotic syndromesThomas L Ortel, Doruk Erkan, Craig S KitchensTherapeutic Advances in Chronic Disease|December 20, 2012
Belimumab in systemic lupus erythematosus: an update for cliniciansSusan S Kim, Kyriakos A Kirou, Doruk ErkanAutoimmunity Reviews|January 29, 2014
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trendsDoruk Erkan, Cassyanne L Aguiar, Danieli Andrade, et al.Current Rheumatology Reports|May 1, 2021
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year UpdateDoruk Erkan, Savino Sciascia, Maria Laura Bertolaccini, et al.Lupus|August 22, 2020
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid SyndromeRicard Cervera, Ignasi Rodríguez-Pintó, Kim Legault, et al.Seminars in Arthritis and Rheumatism|June 27, 2025
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteriaReyhan Kose Cobanoglu, JoAnn Vega, Crystal Burgos, et al.ACR Open Rheumatology|November 22, 2021
When a Diagnosis Has No Name: Uncertainty and OpportunityMichael D Lockshin, Mary K Crow, Medha BarbhaiyaArthritis and Rheumatism|July 13, 2002
Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapyDoruk Erkan, Yusuf Yazici, Melanie J Harrison, et al.Seminars in Thrombosis and Hemostasis|August 23, 2008
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatmentRonald A Asherson, Ricard Cervera, Joan T Merrill, et al.European Journal of Rheumatology|September 7, 2018
Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiologySavinio Sciascia, Massimo Radin, Ozan Unlu, et al.Pageof 18